Atlas Trials

Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients

Clinical trial NCT06065280 · COMPLETED

Trial details

NCT number
NCT06065280
Sponsor
Damanhour University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Heart FailureReduced Ejection Fraction Heart Failure
Start date
2022-11-01
Primary completion
2024-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.